In spite of their high oxidisability, long-chain n-3 PUFA protect against CVD. Dietary fatty acids modulate the fatty acid composition of lipoproteins involved in atherosclerosis. We thought that if long-chain n-3 PUFA were able to increase NO production by the aorta, then by its antioxidant activity the NO will prevent lipid peroxidation. However, the beneficial effect of NO in vivo on VLDL þ LDL oxidation would only be possible if NO could diffuse to their lipidic core. Rats were fed maize oil-or fish oil as menhaden oil-(MO) rich diets for 8 weeks, to study the effects of MO on aortic NO production, NO diffusion into VLDL þ LDL, the extent of oxidation in native VLDL þ LDL and their oxidisability ex vivo. Aortic NO production and its a-tocopherol content were increased and n-3 PUFA were incorporated into the VLDL þ LDL. In spite of the higher peroxidisability and the low a-tocopherol in native VLDL þ LDL from rats fed MO, native VLDL þ LDL from the two groups shared similar electrophoretic patterns, conjugated dienes, thiobarbituric acid-reactive substances, total antioxidant capacity, and NO diffusibility on VLDL þ LDL, indicative of an in vivo protection against oxidation. However, these results do not correlate with the ex vivo oxidisability of VLDL þ LDL, as NO is lacking. Thus, the in vivo beneficial effects can be explained by increased a-tocopherol in aorta and by a compensatory effect of NO on VLDL þ LDL against the low a-tocopherol levels, which may contribute to the anti-atherogenic properties of fish oil.
According to the lipoprotein-oxidative theory, oxidised LDL play an important role in initiating the atherogenic process, partly explaining the link between CVD and the lipid profile (1) . The LDL particle consists of an apolar core of cholesteryl esters and TAG, surrounded by a monolayer of phospholipids, non-esterified cholesterol, and one molecule of apo B-100. Cholesteryl esters are the predominant lipid class in LDL, are rich in PUFA and thus easily attacked by free radicals. a-Tocopherol, the most abundant antioxidant in LDL provides protection to lipid components in LDL.
It has been described that NO also plays a determinant role in the prevention of lipid oxidation. NO readily crosses cell membranes, concentrates in lipophilic milieu where it reacts to terminate propagation reactions catalysed by lipid alkoxyl and peroxyl radical species (2) and spares a-tocopherol (3, 4) . NO can also diffuse into the lipidic core of the lipoproteins, inhibiting lipid peroxidation processes by these chain-breaking antioxidant properties (5, 6) . Another antioxidant factor is paraoxonase-1 (PON-1), which is associated with HDL that degrades lipid hydroperoxides protecting LDL from oxidation (7) . Consumption of fish oil or EPA (20 : 5n-3) or DHA (22 : 6n-3) is associated with protection against CVD (8, 9) . One of the mechanisms, which have been demonstrated both in human (10) and in rat arteries (11) , involves increases in endothelium-dependent vascular relaxation through up-regulation of the endothelial NO synthase -cGMP pathway (12) . Longchain n-3 PUFA are readily oxidised in vitro in homogeneous systems. However, compared with the intake of n-6 fatty acids, the intake of n-3 fatty acids prevents the so-called free radical diseases. This suggests that lipid peroxidation in vivo may not correspond with that in vitro (13) . For instance, several studies have observed that increasing the dietary intakes of EPA and DHA does not increase the oxidative susceptibility of LDL lipoproteins (14 -16) . Since molecular order and dynamics within membranes are known to be dependent on acyl chain unsaturation it was generally anticipated that lipid fluidity within lipoproteins will increase when enriched with long-chain n-3 PUFA, which in turn will increase O 2 diffusibility (17) . As the physico-chemical properties of O 2 and NO are very similar it was likely that the diffusibility of NO might also be improved.
In the present study we aim to provide new insights into the beneficial effect of fish or fish oil on the prevention of atherosclerosis through the antioxidant activity of NO, to contribute to understanding the mechanism of action of long-chain n-3 PUFA. We evaluated the effects of an increase in NO generation at the vascular wall on its a-tocopherol content and the diffusion of NO into native lipoproteins. Additionally, we examined by electrophoretic mobility and, through the conjugated dienes (CD), thiobarbituric acid-reactive substance (TBARS) generation and antioxidant levels whether native VLDL þ LDL rich in long-chain n-3 PUFA were already oxidised. The results were contrasted with the susceptibility to oxidation of VLDL þ LDL ex vivo. Furthermore, the contribution of PON-1, an antioxidant enzyme with an indirect action on LDL, was also evaluated.
Materials and methods

Animals and diets
After weaning, two groups of male Sprague-Dawley rats (Harlan Interfauna Ibérica, Barcelona, Spain) were fed semipurified diets containing lipids at 50 g/kg for 8 weeks, as previously described (11, 12) . At the end of the feeding period, rats were fasted for 18 h before exsanguinations by withdrawal of blood from the heart, using heparin as anticoagulant, under sodium urethane (1·5 g/kg intraperitoneally) anaesthesia.
The lipids were either maize oil (CO), rich in linoleic acid (18 : 2n-6), or fish oil as menhaden oil (MO) rich in EPA and DHA. The oils were analysed for tocopherols after extraction with hexane. A sample was mixed with ethanol in the presence of 10 mM-butylated hydroxytoluene and 5 mM-a-tocopheryl acetate (internal standard). After filtration a sample was injected into an HPLC (Merck-Hitachi, Darmstadt, Germany) through a column (LiChrospher 100 RP 18, 250 mm £ 4·6 mm, 5 mm; Amersham) in methanol -water (95:5) as mobile phase subjected to a flux of 1·5 ml/min. UV absorption at 290 nm was recorded. The internal standard recovery was 96-98 %. The CO contained 250 mg RRR-a-tocopherol/kg and 775 mg RRRg-tocopherol/kg, while MO contained 50 mg RRR-a-tocopherol/kg, thereby supplying 16·4 and 2·5 mg a-tocopherol equivalents/kg diet, respectively. The difference in a-tocopherol equivalents in oils was eliminated by adjusting diets to 67 mg RRR-a-tocopherol equivalents/kg by supplementing the CO diet with 75·6 mg/kg and the MO diet with 96·3 mg/kg of all-rac-a-tocopheryl acetate. All dietary components were from Sigma (St Louis, MO, USA) with the exception of mineral (35 AIN-76) and vitamin (10 AIN-76A, vitamin E omitted) mixes, which were obtained from ICN Pharmaceuticals (Costa Mesa, CA, USA). The fatty acid content of CO and MO was evaluated after a direct transmethylation (18) and the fatty acid methyl esters were analysed with an HP5890 series II gas chromatograph fitted with a flame ionisation detector. Samples were injected through the split injection port (split ratio, 30:1) onto a SP 2330 capillary column (30 m £ 0·25 mm, 0·20 mm film thickness; Supelco, Bellefonte, PA, USA) (19) . Individual fatty acids were identified by comparing relative retention times with commercial standards (Nu Chek; Elysian, MN, USA). Heptadecanoic acid was used as an internal standard. The double-bond index ( P each fatty acid % (mol/mol) £ double-bond number) and the theoretical peroxidisability index ( P each fatty acid % (mol/mol) £ (double-bond number 2 1)) were also evaluated. Results are shown in Table 1 . Plasma was stored at 2 808C in the presence of sucrose (60 mg/ml) to prevent changes in the oxidisability indices of lipoproteins during storage. The thoracic and abdominal aorta were dissected out and cut into segments (11) . The procedures and animal care were in compliance with European Union guidelines.
Isolation of VLDL þ LDL and evaluation of their fatty acid composition
It is noteworthy that in rat samples the LDL concentration is the smallest fraction of plasma lipids. This is the opposite of what happens in humans (20) , and this is why we have used VLDL þ LDL.
VLDL þ LDL were isolated following the technique of Esterbauer et al. (21) with modifications. Plasma (3 ml) density was adjusted to 1·063 g/ml by adding solid NaBr and then overlaid with 2 ml of PBS (pH 7·5) containing 0·01 % EDTA adjusted to 1·063 g/ml. Samples were centrifuged at 100 000 g at 48C for 18 h, and the top layer (about 1 ml) was recovered. Excess NaBr and EDTA in VLDL þ LDL were removed using a PD10 column (Amersham Pharmacia Biotech, UK) and VLDL þ LDL were concentrated (Biomax membrane 10 000 Da; Millipore, Bedford, MA, USA). Proteins were quantified by the Bradford method (Bio-Rad, Hercules, CA, USA). The VLDL þ LDL samples were immediately used for electrophoretic studies and oxidation kinetics, and the remaining solution was frozen in the presence of 0·2 mM-butylated hydroxytoluene for a-tocopherol analysis.
The evaluation of fatty acid composition of VLDL þ LDL was conducted as described for dietary oils.
NO production by the aorta and NO diffusion to VLDL þ LDL NO production (22) was studied immediately after extracting the aortae. Two segments of the thoracic aorta (5 -10 mg) from the same rat were stripped, pre-incubated at 378C for 20 min in 1 ml PBS, and then exposed to the spin-trapping agents, 5 mM-diethyldithiocarbamic acid and 50 mMFeSO 4 .7H 2 O, for 30 min. An additional segment was endothelium denuded or pre-incubated for 30 min in the presence of 1 mM-N G -nitro-L-arginine, a NOS inhibitor, to assess the specificity of the assay. Aortic strips were then weighed, frozen in liquid N 2 , and stored at 2 808C for electron spin resonance analysis (11) . The resulting signal corresponded to the difference in intensity between a maximum at 3440 gauss and a minimum at 3470 gauss.
The importance of an increase in NO production by aorta is a function of its ability to diffuse to the lipidic core of VLDL þ LDL. The diffusion study was conducted according to the method of Denicola et al. (5) after incubating VLDL þ LDL with a 0·35 mM-fluorescent probe 1-(pyrenyl)-methyl-3-(9-octadecenoyloxy)-22,23-bisnor-5-cholenate (PMCho). Excess PMCho was eliminated with a PD10 column (Amersham) and the eluate was degassed under Ar. The NO concentration of an aqueous solution had already been determined by oxyhaemoglobin. Lipoprotein-PMCho preparation (10-30 mg/ml) was injected into fluorimeter cuvettes in degassed 0·1 M-PBS. Subsequently, the NO solution was injected gradually, and the fluorescence (excitation wavelength, 347 nm; emission wavelength, 396 nm) was monitored. The results were normalised to a blank and the apparent second-order quenching constants between the excited state probe and NO were calculated from the slope of Stern -Volmer plots.
Oxidative state in vivo
It was important to elucidate whether native VLDL þ LDL were already oxidised and to contrast these results with those of stimulated oxidation of VLDL þ LDL ex vivo.
The electrophoretic mobility of lipoproteins was visualised in plasma, pre-stained with Sudan black subjected to PAGE in a non-denaturing discontinuous gradient from 2 % (at the area of application) to 3 % (in the running gel) (Lipofilm kit; Sebia; Issy-les-Moulineaux, France) at 100 V.
The electrophoretic mobility of apo B-100 in VLDL þ LDL was also evaluated to detect whether the polypeptide was intact. VLDL þ LDL were precipitated with a mixture of acetone and ethanol (1:1, v/v) and then delipidated with diethyl ether at 2 208C. The delipidated lipoproteins were mixed with a buffer containing 2-amino-2-(hydroxymethyl)propane-1,3-diol HCl (15·76 g/l), glycerol (60 g/l) and SDS (60 g/l). SDS-PAGE was performed in a linear gradient (4 -15 %); each well was loaded with 30 ml of sample (2 mg of protein/ml) pre-heated to 808C for 15 min. In some wells, purified apo B-100 (Sigma) was also loaded. Electrophoresis was conducted at 120 V for 2 h. Gels were fixed in 10 % acetic acid and 25 % isopropanol for 10 min, and then stained with Coomassie blue for 1 h. Completely oxidised samples (exposed to 62·5 mM-CuCl 2 for 24 h) were also loaded as a positive control.
The a-tocopherol from 100 mg native VLDL þ LDL protein was extracted with 5 ml water -methanol-hexane (1:1:3, by vol.) in the presence of 10 mM-butylated hydroxytoluene and 5 mM-a-tocopheryl acetate (internal standard). The hexane phase was evaporated under N 2 , dissolved in methanol and injected into an HPLC (Merck-Hitachi, Darmstadt, Germany) through a column (LiChrospher 100 RP 18, 250 mm £ 4·6 mm, 5 mm; Amersham) subjected to a 100 % methanol flux of 1·5 ml/min. UV absorption at 290 nm was recorded. The internal standard recovery was 95 -98 %.
Total antioxidant capacity in VLDL þ LDL was evaluated in 100 mg VLDL þ LDL protein using a kit (Randox Laboratories; Crumlin, Co. Antrim, UK).
TBARS analysis, as evaluation of malondialdehyde, was performed in 10 mg native VLDL þ LDL and in 50 ml plasma at 540 nm and subtracting background absorbance at 620 nm. We used tetraethoxypropane as standard (23) . Butylated hydroxytoluene and EDTA were added to avoid oxidation during the process.
PON-1 activity was measured in 20 ml of plasma after incubation in 100 mM-2-amino-2-(hydroxymethyl)propane-1,3-diol HCl buffer (pH 8·0) in the presence of 2 mM-CaCl 2 and 2 mM-paraoxon (Sigma). Paraoxon degradation to p-nitrophenol was monitored by the absorbance increase at 412 nm (extinction coefficient 18 290 l/mol per cm) for 5 min (24) . One unit (U) of PON-1 corresponds to 1 nmol paraoxon degradation/min.
Aortic a-tocopherol levels were also measured. A segment of abdominal aorta (20 mg) was extracted as described for bcarotene (25) . The tissue was homogenised in 1·5 ml KCl (11·5 g/l) and 0·5 ml ascorbic acid (250 mg/ml); then 2 ml ethanol and 50 ml retinol (0·1 mM) (internal standard) were added and the mixture saponified with 1 ml of 10 M-KOH. The internal standard recovery was 94-98 %. a-Tocopherol was extracted in hexane and evaluated by HPLC at 290 nm in the same conditions as for VLDL þ LDL.
Stimulated oxidation of VLDL þ LDL ex vivo Cu 2þ and 2,2 0 -azobis (2-amidinopropane) dihydrochloride (AAPH) mimic in different ways the oxidation in the vascular compartment. Cu 2þ interacts with an LDL low-affinity binding site and generates Cu þ , which produces chain-propagating radicals (21) . AAPH generates alkoxyl and peroxyl radicals in the aqueous phase, thus triggering lipid peroxidation independently of transition metals (26) . VLDL þ LDL (50 or 25 mg protein/ml for Cu 2þ and AAPH, respectively) in oxygenated PBS at pH 7·4 were incubated at 308C, either with 1·25 mM-CuCl 2 or 1 mM-AAPH. The formation of CD was monitored by absorbance at 234 nm for 6-8 h (21) . The background signal of an AAPH solution (1 mM) was subtracted from the absorbance values of lipoprotein oxidation assay. The lag time, the oxidation rate and the maximum amount of CD formed (molar extinction coefficient of 29 500 M/cm) were calculated.
Statistical analysis
Data are expressed as mean values with their standard errors. The results from MO-fed rats were compared with those obtained from CO-fed rats by the Student's t test for unpaired observations.
Results
Body weight
There were no differences in either the growth or final body weight of rats after 8 weeks of diet (328 (SE 6) and 323 (SE 9) g for the CO and MO diets, respectively). Food consumption was also similar in both animal groups.
NO production by the aorta and NO diffusion into VLDL þ LDL After incubating aortic segments with 1 mM-N G -nitro-L-arginine, the more prominent electron spin resonance signal was reduced by 90-95 % in all groups, indicating that the signal corresponds to NO. The MO diet induced a 130 % increase in aortic NO production ex vivo ( Fig. 1 (a) ). The endothelium-denuded segments gave a weak signal in all groups, indicating that the endothelium is the main source of NO. NO diffusion into the lipidic cores of VLDL þ LDL was similar in both groups. The Stern-Volmer plots were 2·0 (SE 0·4) and 1·7 (SE 0·4) litres/mmol for CO-and MO-fed rats, respectively ( Fig. 1 (b) ).
Oxidative status in native VLDL þ LDL in aorta and in plasma Native VLDL and LDL from rats fed either a CO-or an MO-rich diet showed similar electrophoretic mobility in a non-denaturing gel (Table 2) . Electrophoretic mobility of apo B-100 was similar in both dietary groups (Table 2) . However, after oxidation by ex vivo exposure to Cu 2þ , apo B-100 from rats fed CO-or MO-rich diets was degraded.
The levels of CD in VLDL þ LDL were similar in both dietary groups ( Table 2) .
The total antioxidant capacity in VLDL þ LDL from both groups was not statistically different (Table 2) .
There was a 23 % decrease (P, 0·001) in the a-tocopherol content of VLDL þ LDL from rats fed the MO diet compared with rats fed the CO diet (Table 2) . Conversely, there was a 78 % increase (P, 0·001) in the aortic tissue a-tocopherol content of rats fed the MO-rich diet (32 (SE 3) pmol/mg tissue) compared with rats fed the CO-rich diet (18 (SE 2) pmol/mg tissue) (Fig. 2) .
We observed no significant differences in the concentration of TBARS either in native VLDL þ LDL (Table 2 ) or in plasma (Table 3) .
Similar PON-1 activity in plasma was detected in the two dietary groups (Table 3) .
Fatty acid composition of VLDL þ LDL and stimulated oxidation of VLDL þ LDL ex vivo
The fatty acid composition of VLDL þ LDL is shown in Table 4 . The more notable differences appeared in total n-6 and n-3 PUFA content, which prevail in the lipoprotein fractions of CO-and MO-fed rats, respectively. Thus, VLDL þ LDL from CO-fed rats showed higher levels of linoleic acid, g-linolenic acid (18 : 3n-6), arachidonic acid (20 : 4n-6), and 22 : 5n-6, while lipoproteins from MO-fed rats showed higher EPA and DHA content. While the theoretical peroxidisability index in rats fed the MO-rich diet was higher than in rats fed the CO-rich diet, due to the levels of highly unsaturated fatty acids, the double-bond index was similar in both dietary groups.
The MO-rich diet altered the oxidation susceptibility of VLDL þ LDL when exposed to 1·25 mM-CuCl 2 or to 1 mM-AAPH ( Fig. 3 (a) ). With Cu 2þ as catalyst, the lag time before the increase in CD was shortened (33 %; P, 0·01) in the lipoproteins of rats fed the MO-rich diet (89 (SE 4) and 60 (SE 5) min for CO and MO, respectively) ( Fig. 3 (b) ). The oxidation rate of fatty acids was 47 % lower (P, 0·001) in lipoproteins from rats fed the MO-rich diet (152 (SE 12) mmol CD/g protein per min) compared with rats fed the CO-rich diet (289 (SE 10) mmol CD/g protein per min) Fig. 1 . Aortic NO production measured by electron spin resonance (a) and NO diffusion rate into VLDL þ LDL calculated from the slope of Stern -Volmer plots (b) in rats fed a maize oil-(CO) or menhaden oil-(MO) rich diet. Values are the means of six rats per diet with their standard errors represented by vertical bars. *** Mean value was significantly different from that of the CO group (P, 0·001). Rf, retention factor; CD, conjugated dienes; TBARS, thiobarbituric acid-reactive substances. *** Mean value was significantly different from that of the maize oil group (P,0·001). † For details of diets and procedures, see Materials and methods.
( Fig. 3 (c) ). The maximum CD concentration was also reduced (27·0 (SE 1·1) v. 19·8 (SE 0·7) mmol CD/g protein for CO and MO, respectively, P, 0·001) ( Fig. 3 (d) ).
When lipoproteins were exposed to the free radical generator AAPH, similar behaviour to Cu 2þ -induced lipoprotein oxidation was observed in the two dietary groups (Fig. 3 (a) ). The lag times were 172 (SE 15) and 122 (SE 15) min for CO and MO, respectively (P,0·05) ( Fig. 3 (b) ), which represents a reduction of 29 %. The oxidation rates of fatty acids were 89 (SE 10) and 50 (SE 5) mmol CD/g protein per min for CO and MO, respectively (P, 0·001), which represents a 43 % decrease (Fig. 3 (c) ). The maximum CD concentration was also reduced (13·4 (SE 1·1) v. 7·1 (SE 0·8) mmol CD/g protein for CO and MO, respectively, P,0·01) (Fig. 3 (d) ).
Discussion
The protective effect at cardiovascular level of long-chain n-3 PUFA present in fish and fish oils has been usually attributed to anti-arrhythmic, anti-thrombotic and anti-inflammatory effects, a reduction of blood pressure and TAG levels, improvement of endothelial function, and also prevention of atherosclerosis (9, 11, 12, 27) . The present paper gives for the first time new insights (tocopherol content in VLDL þ LDL and aorta, ex vivo susceptibility of VLDL þ LDL to oxidation by Cu 2þ and AAPH, and PON-1) into the physiological mechanism involved in the beneficial effects of increased endothelial NO production on the vascular wall in rats postulated by our group in previous papers where the 5 % of lipids of the diet were substituted by CO or MO (11, 12) . NO is a potent antioxidant (5, 6) but this activity can only be manifested when pro-oxidative reactions do not prevail, since NO may interact with O z2 2 to yield peroxynitrite, which promotes LDL oxidation (3) . Whether peroxynitrite is formed in vivo and exerts any physiological or pathological activity remains a subject of debate. We previously observed, in similar conditions, no increase in O z2 2 production from an MO-rich diet but induced NO-mediated vasorelaxation in tandem (11) . Thus, the final result may be a net gain of free NO (28) . In the present paper, we observe an endothelium-dependent NO increased production by MO that can be related to previous observations on increased NO concentrations in plasma (29) and urine (30) from human subjects or in plasma from rats (31) , both indices of NO-enhanced production by fish oil-supplemented diets.
It has been described that NO concentrates in lipophilic milieu by virtue of its uncharged character, low molecular mass, and relatively high lipid/water partition coefficient (32) . The NO generated at the vascular wall can act directly or through the generation of nitroalkenes by its reaction with PUFA, which eventually will release NO (33) . Moreover, nitroalkenes, which reduce inflammation (34) , may also contribute to the protection against atherosclerosis. We have observed that the MO-rich diet is associated with an increase in a-tocopherol in the aortic tissue. As both the CO and MO diet were not deficient in vitamin E but contained similar tocopherol equivalents and in excess of requirements, the increased tocopherol content with MO is unlikely to be the cause of enhanced NO production through activation of endothelial NO synthase via phosphorylation of serine 1177 in the enzyme (35) but we attribute the increase in endothelial NO to the long-chain n-3 PUFA. The high levels of a-tocopherol may be explained by two contributions. First, additional RRR, RSR, RRS and RSS isomers reached the aorta from the liver because of the excess of all-rac-a-tocopherol supplemented to the MO diet (20·7 mg/kg or 27·4 %) compared with the high content of g-tocopherol in the CO diet (38·7 mg/kg), despite the attempts to equalise tocopherol equivalents. Second, because of its antioxidant activity, NO can spare a-tocopherol from oxidation (3, 4) . NO is able to diffuse to the lipidic core of LDL from the vascular wall (5) and react with radical species at near diffusion-limited rate (4) . In the present study we in fact failed to detect a difference in the ex vivo ability of chemically generated NO to reach the lipidic core of lipoproteins enriched either with n-3 PUFA or n-6 PUFA. However, the greater amount of NO generated by the MO-rich diet compared with the CO-rich diet will be equally able to diffuse into VLDL þ LDL and act as antioxidant in situ. We observed that native VLDL þ LDL from MO-fed rats had a higher peroxidisability index and that these lipoproteins carry much less total PUFA than those isolated from animals fed a diet enriched in CO as observed by Thomas et al. (36) . The absence of differences in electrophoretic mobility of either whole lipoproteins or apo B-100, together with lack of difference in CD, TBARS and total antioxidant capacity in VLDL þ LDL, and in TBARS and PON-1 in plasma from the two dietary groups, even at the high dose of fish oil used in the present paper, supports the idea that these native lipoproteins are not more oxidised in vivo in spite of a lower a-tocopherol content. It should be emphasised that fish oil decreases the VLDL levels (37) and thus the a-tocopherol plasma levels (37, 38) . The absence of increased oxidation in native VLDL þ LDL with an increased peroxidisability index compared with rats fed a diet enriched in CO may be due to the increased NO availability, which counteracts the decrease in a-tocopherol. However, in the current in vivo study it was not possible to provide evidence of NO sparing a-tocopherol.
NO is a potent antioxidant that can diffuse in situ into lipoproteins. However, as a gas it was absent in the ex vivo assays, and thus the antioxidant effect of the increased NO production on preventing lipoprotein oxidation cannot be demonstrated in those conditions. We observed alterations in the ex vivo susceptibility to oxidation in the MO group when oxidising agents such as Cu 2þ and AAPH were used. The shortening of the lag time on rats fed an MO-rich diet can be related to the lower levels of a-tocopherol. In this sense, Napolitano et al. (39) detected a decrease in a-tocopherol in chylomicron remnant preparations from rats treated with fish oil in comparison with rats treated with CO. The reduction in oxidation rate (40) and maximum CD formation can be related either to a lower concentration of PUFA or to a more rapid decomposition of CD derived from n-3 PUFA. Reductions of lag time and oxidation rate were also shown in LDL from longchain n-3 PUFA-fed rats (14, 36) and human subjects (16, 41, 42) . These paradoxical results suggest the involvement of a differential distribution of fatty acids in LDL. The long chain n-3 PUFA are found in cholesteryl esters and TAG present in the core of LDL, while linoleic acid is found in surface phospholipids (39) . We can consider, in agreement of Higdon et al. (14) , that the overall total oxidation of the VLDL þ LDL particles was not increased by the MO-rich diet. However, results from different studies are contradictory. While some researches reported no difference in susceptibility of LDL particles to oxidation with fish-oil supplementation (29, 43, 44) , others found a decrease (45) or even an increase (27, 46) . Differences in study design, the supplementation dosage, the use of unreliable tests or of oxidised dietary oils may explain partly these inconsistent results.
We have to take into consideration that in the oxidation of lipoproteins ex vivo, a-tocopherol and total PUFA are involved and that NO is not present. We have thus demonstrated by different techniques that native lipoproteins were not more oxidised and that the resistance of VLDL þ LDL to oxidation ex vivo does not reflect their in vivo behaviour as relevant factors such as NO are lacking.
HDL-associated PON-1 prevents LDL oxidation (7) and represents another mechanism by which long-chain n-3 PUFA could exert their beneficial effect at cardiovascular level. No information is currently available on the effects of fish oil on PON-1 activity in healthy humans or animals and the lack of any effect in the present study rules out an in vivo modulation of LDL oxidation by fish oil via HDL. Mean value was significantly different from that of the maize oil group, *P,0·05, **P, 0·01, ***P, 0·001 (Student's t test). † For details of diets and procedures, see Materials and methods.
Moreover, the similar levels of TBARS and PON-1 in plasma corroborate the absence of increased lipid peroxidation by a fish oil-rich diet.
It has been demonstrated that fish oil has a broad spectrum of beneficial effects. The increased endothelial NO production, induced in vivo, is indicative of a compensatory protective mechanism in inflammatory and vascular diseases and may be related to an increase in a-tocopherol. In the present paper, we demonstrate beneficial effects of fish oil in aortic tissue and non-deleterious effects on VLDL þ LDL in spite of a higher peroxidisability index. It is likely that the fish oil-mediated NO increase and the absence of differences in the rate of diffusion into the VLDL þ LDL lipidic core are additional crucial mechanisms involved in the anti-atherogenic properties of fish and fish oils. represented by vertical bars (two replicates from six rats per diet). Mean value was significantly different from that of the CO group: *P, 0·05, **P, 0·01, ***P, 0·001.
